Trandolapril Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.5 mg, 1 mg, 2 mg
Reference Brands: Mavik (USA), Gopten (EU)
Category:
Heart Disorder
Trandolapril is available in Tablets
and strengths such as 0.5 mg, 1 mg, 2 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Trandolapril is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Trandolapril can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Trandolapril is an angiotensin-converting enzyme (ACE) inhibitor used primarily to manage high blood pressure (hypertension) and improve heart function. It works by blocking the conversion of angiotensin I to angiotensin II, a substance that narrows blood vessels, thereby relaxing the vessels and lowering blood pressure. This action reduces the workload on the heart and improves blood flow throughout the body.
Trandolapril is a prodrug, meaning it is metabolized in the body into its active form to exert therapeutic effects. Structurally related to ramipril, it contains a cyclohexane group that contributes to its potency. Compared to other ACE inhibitors, trandolapril has a longer half-life, allowing for convenient once-daily dosing and sustained blood pressure control.
The medication is administered orally and may be used alone or in combination with other antihypertensive agents. Regular monitoring of blood pressure, kidney function, and electrolyte levels is recommended to ensure safety and effectiveness. Trandolapril’s established efficacy and prolonged action make it a reliable choice for long-term management of hypertension and related cardiovascular conditions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing